They found that CARD9−/− mice could not control infection (even when challenged with a BAD1 deletion hypovirulent mutant), and the mutant mice did not respond to immunization with killed B. dermatitidis yeast, indicating that a CLR was required for both innate and acquired immunity. The gene discussed is CARD9; the disease is infection.